Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anvil (officially Anvil Informatics, Inc.) is a biotechnology company building a platform for the discovery and development of programmable medicines. Founded by former Palantir engineers and leaders, the company leverages a sophisticated computational and experimental infrastructure to design precision therapies. Anvil's approach focuses on creating 'programmable' treatments that can be precisely controlled and targeted, aiming to address complex diseases with high unmet needs. The company operates at the intersection of data science and biology, utilizing large-scale genomic and proteomic data to inform its drug discovery process. By integrating advanced data engineering with biological insights, Anvil aims to accelerate the path from target identification to clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AnVil Informatics.